Immediate Impact

1 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
2025 Standout
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
2025 StandoutNature
2 intermediate papers

Works of Reed Johnson being referenced

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
2017
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study
2017

Author Peers

Author Last Decade Papers Cites
Reed Johnson 283 55 44 124 13 353
Marcelo Merello 265 52 35 130 17 342
Rita Miguel 218 56 44 106 15 318
Th. M�ller 227 79 32 85 10 339
Christine Girges 218 78 38 86 16 391
Muenter 358 36 35 148 8 409
Vivian Altmann 197 92 23 118 17 311
Pavel Ressner 318 50 48 126 23 381
Kelly Bertram 285 77 31 111 20 351
J López del Val 173 38 70 97 24 333
Jerry L. Morris 267 67 47 72 14 361

All Works

Loading papers...

Rankless by CCL
2026